UNSPSC 51241219: Tazarotene

This classification denotes a retinoic acid agent with the molecular formula C21H21NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81BDR9Y8PS, chemically known as 3-pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2h-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester but generally known as tazarotene, which bears US NIH Compound Identifier 5381. European Medicines Agency schedules Tazarotene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10844MIG.

UNSPSC 51241219 Tazarotene is a Commodity code that classifies a specific topical retinoid pharmaceutical, yet recent state and local procurement activity under this code does not reflect purchases of tazarotene itself. The City of Tampa Fire Rescue Department's ITB 25-P-00157, posted April 24, 2026, shows the code applied to a broad medical aid supplies solicitation spanning 32 items including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets with an estimated annual budget of $100,000. The mismatch between the code's pharmaceutical scope and the actual procurement of general first aid consumables suggests either a classification error in the source data or that this code has seen limited relevant activity in recent state and local contracting.

The single identified opportunity originates from a city fire-rescue department in Florida. The Tampa solicitation used ITB notice type with a response date of April 9, 2025, and included set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) offering a 5% bid discount (not to exceed $10,000) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs) offering a 5% discount (not to exceed $20,000). The procurement structure anticipated an initial one-year award period with potential for two additional one-year renewals, with the City reserving the right to award by aggregate total or individual line items. All medications required a minimum nine-month expiration date from acceptance, and vendors needed to submit documentation including business licenses, minority business status certifications, conflict of interest disclosures, and criminal history screening practices.